Machine Learning

The firm reports a $195M cash reserve but a wider net loss as it nears crucial data readouts for its novel depression and anxiety drug candidates.

Alto Neuroscience completes enrollment for a trial of its skin patch drug, ALTO-101, offering new hope for the millions battling cognitive decline in schizophrenia.

A new software upgrade uses AI to make low-cost drones perform like high-end systems, a breakthrough with major implications for defense and industry.

Comparor launches its AI assistant, joining a tech race to simplify shopping and find the best price. But what does this mean for you and for retailers?

Vibrant festivals in Cairo and Rabat celebrate the Chinese New Year, revealing a strategic cultural diplomacy effort to deepen ties in the Middle East.

After a record-breaking local robotics contest, Hong Kong's brightest young minds are preparing to showcase their I&T prowess on the world stage.

After its lead anxiety drug failed a key trial, Vistagen turns to AI and a new menopause treatment to secure its future. Can the company recover?

Fermi America's plan to revive nuclear power for AI's energy needs with a massive Texas campus faces past industry failures and new legal scrutiny.

The firm behind a controversial drug-permissive sporting event is hitting Wall Street via a SPAC, challenging the ethics of global anti-doping standards.

Vitalist reports soaring losses and a $6.4M debt surge, raising 'going concern' alarms. Can its new Reebok smartwatches and VitalOS™ platform save it?

With strong financials and a focus on tech, Allegion's CEO will outline the security giant's long-term strategy for a digitally connected world.

With top executives set for major conferences, investors eye Mastercard's playbook for commercial payments and Americas growth amid fierce competition.

Lay's emotional 'Last Harvest' was America's top Super Bowl ad, but a new report reveals a huge generational divide, with Gen Z crowning a different winner.

A new 'longevity center' in Naperville signals a growing trend in proactive health, but what does this mean for the Chicago wellness landscape?

Aethlon Medical advances its Hemopurifier for oncology and Long COVID, but a shrinking cash reserve and rising quarterly loss test its lean science strategy.

The SaaS firm posts strong net income and recurring revenue growth from its B2B platform, offsetting a decline in its transactional business.

The streaming pioneer smashed Q4 estimates and returned to full-year profitability, signaling a strong 2026 with ambitious growth targets for its ad platform.

Brazil's fintech leader reports a record R$5.2B adjusted net income for 2025, outlining a strategy that pairs AI with human advisors to win the market.

LA Fitness and Shoot 360 are launching smart basketball courts in their gyms. Can AI and gamification revolutionize how amateurs train and compete?

Helsinki pioneers a revolutionary cancer therapy, offering new hope with a targeted neutron beam that destroys tumors in just one or two sessions.